An Open-Label Study of Effectiveness of Immunomodulatory Medications for Patients With Relapsing Polychondritis

Abroad (travel likely)RecruitingPHASE2

Conditions

Relapsing Polychondritis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Pennsylvania, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Jessica Nguyen) · Jessica.Nguyen2@PennMedicine.upenn.edu

Study leads

Shubhasree Banerjee, MD
Principal Investigator
University of Pennsylvania

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Efficacy, Safety and Immunological Evaluation of Upadacitinib for Relapsing Polychondritis

Relapsing Polychondritis

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China

Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis

Takayasu's Arteritis · Giant Cell Arteritis · Polyarteritis Nodosa

Abroad (travel likely)Recruiting

Bethesda, United States

Longitudinal Study for Relapsing Polychondritis

Relapsing Polychondritis · Vasculitis

Abroad (travel likely)Recruiting

Philadelphia, United States